Careinner vs 快舒尔健康 Uso e estatísticas

Careinner, Professional chronic disease management APP for endocrinologists and patients. Link between monitoring and treatment equipment and real-time control of the disease process and treatment; Automatic analysis of key medical information to better manage patient data and the life cycle of chronic diseases; Platform for chronic disease care network to easily share information of clinical practice and scientific research. Support patients with real-time medical management; Help patients adhere to standard treatment; Let patients to facilitate communication with doctors; Set up communication and learning bridge between patients. Allow doctors to easily query medical records; Assist doctors for chronic disease management ; Help doctors perform the clinical study; Promote hospital to establish patient care network. Disclaimer: The hardware equipment connected by Careinner has been registered and licensed in China, the Philippines, Malaysia, Singapore, Thailand and EU countries, and is subject to the supervision of relevant departments. The content of the Careinner application is for reference only. The content in the application should not be used as the basis for diagnosis, medication and use, and cannot replace the advice of the in-person diagnosis doctor and other medical staff. If you encounter any problems, please seek medical attention in time.
  • Apple App Store
  • Gratuitos
  • Médico

Ranking da Loja

- -

免责声明:本APP不提供任何的医疗决定服务。如您有任何的医疗决定时,请及时前往专业医疗机构寻求医生建议。
  • Apple App Store
  • Gratuitos
  • Médico

Ranking da Loja

- -

Careinner versus 快舒尔健康 comparação de classificação

Compare a tendência de classificação de Careinner nos últimos 28 dias versus 快舒尔健康

Classificação

Nenhum dado disponível

Comparação da classificação de Careinner vs. 快舒尔健康 por país

Compare a tendência de classificação de Careinner nos últimos 28 dias versus 快舒尔健康

Nenhum dado para exibir

Faça comparações com qualquer site com o nosso teste grátis

Comece agora
Careinner VS.
快舒尔健康

23ezembro d, 2024